NCT04069065 - Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) | Biotech Hunter

Enrollment

146

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

February 22, 2021

Study Completion Date

April 8, 2021

Conditions

Liver Transplant

Interventions

DRUG

Conversion to Once-daily Tacrolimus

"* Orally, once-daily in the morning~* The first dose is converted to approximately 100% of the existing daily dose, taking into account the subject's blood concentration, after which the investigator check the blood concentration of tacrolimus at each visit and adjust the dose to achieve the blood concentration maintaining at 3\~10ng/ml."

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul